SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists
Chun‐Kit Yuen(University of Hong Kong), Kin‐Hang Kok(University of Hong Kong), Kelvin Kai‐Wang To(Hong Kong Science and Technology Parks Corporation), Wan‐Man Wong(University of Hong Kong), Dong‐Yan Jin(University of Hong Kong), Hin Chu(HKU-Pasteur Research Pole), Jasper Fuk‐Woo Chan(Hong Kong Baptist University), Jian‐Piao Cai(University of Hong Kong), Joy-Yan Lam(University of Hong Kong), Xiaohui Wang(First Affiliated Hospital Zhejiang University), Kwok-Yung Yuen(University of Hong Kong - Shenzhen Hospital), Long-Fung Mak(University of Hong Kong)
Cited by 556
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k